Chemkart India Limited Sets October 30 Board Results Meeting

Chemkart India Limited has scheduled a board meeting for October 30, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The meeting follows FY26 consolidated revenue of ₹214.83 crore, while the company has also filed its seventh annual report for FY26 under SEBI regulations.

When will Chemkart India announce its H1 FY27 results?

Chemkart India will consider and approve its unaudited standalone and consolidated financial results for the half year ended September 30, 2026, at a board meeting scheduled for October 30, 2026. The company disclosed the meeting through a BSE filing dated October 18, 2026.

The agenda specifically concerns the first half of FY27. This is distinct from the company’s earlier FY26 board process, when the board considered audited standalone and consolidated results for the half year and full year ended March 31, 2026, at its May 18, 2026 meeting.

Chemkart India has also stated that the trading window for designated persons is closed until 48 hours after the financial results are declared. The closure is in line with SEBI’s insider trading rules and restricts dealing in the company’s securities during the period surrounding the results announcement.

The October meeting is relevant for investors because it will provide the first reported view of Chemkart India’s FY27 performance. The filing does not provide guidance, projections, or preliminary H1 FY27 operating figures.

What did Chemkart India report for H2 FY26 and FY26?

Chemkart India reported consolidated revenue from operations of ₹111.60 crore for the half year ended March 2026, compared with ₹103.23 crore in the preceding half year. Consolidated net profit was ₹9.51 crore, versus ₹10.15 crore in the half year ended September 2025.

The company’s H2 FY26 revenue was also reported at ₹11,160.4 lakh, equivalent to ₹111.60 crore, with a year-on-year increase of 23.8% in the supplied results data. Net profit of ₹950.3 lakh, or ₹9.50 crore, was stated as 6.8% higher year on year in that disclosure. The half-year comparison data, however, shows a 6.31% decline in net profit from the immediately preceding September 2025 half year.

For the full financial year ended March 2026, Chemkart India reported consolidated annual revenue of ₹214.83 crore. The annual revenue table rounds this figure to ₹215 crore, compared with ₹203 crore for FY25. Another reported annual-results summary listed standalone FY26 revenue at ₹213.55 crore, EBITDA at ₹29.90 crore, net profit at ₹20.77 crore, and earnings per share of ₹18.24.

Why did Chemkart India’s FY26 profitability moderate?

Chemkart India’s reported FY26 profitability moderated as expenses increased and margins declined. A full-year earnings summary reported net income of ₹19.66 crore, down 20% from FY25, and a profit margin of 9.2%, compared with 12% in the previous year. The same summary attributed the margin decline to higher expenses.

The consolidated half-year data also shows pressure on operating profitability. Operating profit excluding other income was ₹14.01 crore in H2 FY26, marginally lower than ₹14.16 crore in H1 FY26, while operating profit margin declined by 1.17 percentage points to 12.55%.

Purchases of traded goods remained the largest expense line in H2 FY26 at ₹103.65 crore, against ₹74.94 crore in H1 FY26. Total expenses increased to ₹97.83 crore from ₹89.32 crore. Interest expense declined to ₹0.67 crore from ₹0.78 crore, but that reduction did not offset the movement in operating costs and margin.

The company reported FY25 revenue of ₹203.00 crore and net profit of ₹24.53 crore. The FY26 figures therefore indicate continued revenue growth but lower reported annual profitability compared with the prior year.

How does the SEZ manufacturing plan matter for Chemkart India?

Chemkart India has stated that it is transitioning from trading to manufacturing through a new special economic zone, or SEZ, facility. Its H2 FY26 expenditure profile indicates that purchases of traded goods were still a major component of costs during the period.

The transition is important because a manufacturing facility represents a change in the company’s operating model from its existing trading-led activity. The supplied disclosures do not specify the facility’s commissioning date, investment amount, production capacity, products, or expected financial contribution. As a result, the October results will be assessed primarily on reported financial performance rather than assumptions about the facility.

Alongside the FY26 results and annual-report filing, Chemkart India appointed new internal and secretarial auditors. These appointments were disclosed as measures to strengthen corporate governance. The company filed its seventh annual report for FY25-26 as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

For investors, the immediate focus remains the H1 FY27 revenue, operating margin, profit and cash-flow disclosures that emerge from the October 30 board meeting. The results may also offer updated company disclosures on the progress of the manufacturing transition if the board-approved financial filing includes them.

Conclusion

Chemkart India enters its October 30 board meeting after FY26 revenue reached ₹214.83 crore, while its reported profit and operating-margin data showed moderation. The H1 FY27 results will be important for measuring whether revenue growth has continued and whether the expense pressure visible in FY26 has changed.

Investors should watch for the unaudited standalone and consolidated results for the half year ended September 30, 2026, and the disclosure issued after board approval. The company has not disclosed an earnings target or a timetable for the new SEZ manufacturing facility, leaving those matters unresolved in the available filings.